1478 / 1835
RT in GHSG BEACOPP Studies (1)
•
HD 9
established the advantage of escalated BEACOPP. It
included 30-40 Gy IFRT to over 2/3 of patients (bulky and/or
residual disease).
•
In
HD 12
esc. BEACOPP cycle reduction and randomization to
+/- RT were studied.
•
Less esc. BEACOPP was inferior to 8 esc. BEACOPP, but not less
toxic.
•
FFTP was inferior with no RT particularly if residual CT
abnormality. “Our results do not support the omission of
consolidation RT for patients with residual disease”.
.
22